CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 03:30PM GMT
Release Date Price: R$40 (+0.40%)
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - Analyst

I don't think this is -- oh, now it's working, and I'm loud.

Karen Sue Lynch
CVS Health Corporation - President, CEO & Director

Well, thank you, Lisa. Good morning, everyone, and Happy New Year. I'm really thrilled to be with you today to talk about CVS. And as Lisa said, I'm joined by our brand-new CFO, Tom Cowhey, and I couldn't be more thrilled that he is in the role. And I have every confidence that he will continue to help us execute on our strategy and deliver our financial commitments.

One housekeeping item before I talk about CVS Health. This presentation contains forward-looking statements and uses non-GAAP measures. And I would encourage everyone to consult our SEC filings and non-GAAP reconciliation that's available on the Investor Relations portion of our website.

So now that that's over, let me talk a little bit about CVS Health. First and foremost, our mission is to build a world of health around every consumer. And as a company, we are committed to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot